How Much Did Lumatas Biosystems Raise?
Funding & Key Investors

Lumatas Biosystems has successfully secured a major strategic investment, marking a significant milestone in its corporate trajectory. This latest infusion of capital brings the firm's total funding to $150K, with the most recent round contributing $150K to its balance sheet. As the company transitions through this late-stage growth phase, the influx of resources underscores investor confidence in its specialized biomedical diagnostic platform and its capacity to scale operations within the competitive clinical pathology market.

What is Lumatas Biosystems?

Lumatas Biosystems
ManufacturingTest & Measurement Equipment

Headquartered in Silicon Valley, Lumatas Biosystems operates at the intersection of advanced engineering and clinical diagnostics. The company specializes in the research, development, and manufacturing of sophisticated biomedical machinery, with a primary focus on the automation of Immunohistochemistry (IHC) staining processes. By deploying proprietary technologies such as the Titan and Titan S autostainers, Lumatas enables laboratories and hospitals to achieve high-precision analysis of antigen distribution in tissue sections. This capability is critical for the accurate diagnosis of complex diseases, including various forms of cancer. Through its strategic partnership with Maxim Biotechnologies, the firm has solidified its market position as a reliable provider of high-efficiency diagnostic solutions, effectively bridging the gap between laboratory research and clinical application.

How much funding has Lumatas Biosystems raised?

Lumatas Biosystems has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Lumatas Biosystems

PPP

Public-Private Partnership

What's next for Lumatas Biosystems?

With the successful closure of this late-stage financing, Lumatas Biosystems is well-positioned to accelerate its commercial expansion and deepen its penetration into the global diagnostics sector. The strategic deployment of these funds will likely prioritize the enhancement of its autostainer product line and the expansion of its distribution network to meet the rising demand for automated pathology workflows. As the company matures, the focus will shift toward optimizing operational efficiencies and potentially exploring new diagnostic modalities that leverage its existing expertise in biomedical automation. By maintaining its commitment to reliability and diagnostic accuracy, Lumatas is poised to play an increasingly vital role in the evolution of precision medicine and oncology diagnostics.

See full Lumatas Biosystems company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturing
ManufacturingTelecommunication EquipmentElectronics
FurnitureManufacturingRetail
ManufacturingTextiles & ApparelFurnitureRetail

Frequently Asked Questions Regarding Lumatas Biosystems Financial Insights

What are the most recent funding rounds that Lumatas Biosystems has completed, and what were the funding rounds?
Lumatas Biosystems has recently completed 1 funding rounds: Debt on May 3, 2020.
What is the total amount of funding Lumatas Biosystems has raised to date?
Lumatas Biosystems has raised a total of $150K in funding to date.
How many funding rounds has Lumatas Biosystems completed?
Lumatas Biosystems has completed 1 funding rounds.
How much funding did Lumatas Biosystems raise in its most recent funding round?
Lumatas Biosystems raised $150K in its most recent funding round.
Who are the lead investors in Lumatas Biosystems's latest funding round?
The lead investor in Lumatas Biosystems's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Lumatas Biosystems's history?
The largest funding round in Lumatas Biosystems's history was $150K.
See more information about Lumatas Biosystems